DHC
Diversified Healthcare Trust
Price Chart
Latest Quote
$8.86
| Previous Close | $8.59 |
| Open | $8.27 |
| Day High | $9.06 |
| Day Low | $8.27 |
| Volume | 3,369,117 |
Stock Information
| Quarterly Dividend / Yield | $0.04 / 0.45% |
| Shares Outstanding | 242.11M |
| Quarterly Dividend Yield | 0.45% |
| Quarterly Dividend | $0.04 |
| Total Debt | $2.42B |
| Cash Equivalents | $121.77M |
| Revenue | $1.52B |
| Net Income | $-320.18M |
| Sector | Real Estate |
| Industry | REIT - Healthcare Facilities |
| Market Cap | $2.15B |
| EPS (TTM) | $-1.33 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $4.44B |
| Sales | $1.52B |
| Income | $-320.18M |
| Book/sh | $6.69 |
| Cash/sh | $0.50 |
Financial Ratios
| Quick Ratio | 6.74 |
| Current Ratio | 7.40 |
| Debt/Eq | 149.23 |
Returns & Margins
| ROA | -0.53% |
| ROE | -17.94% |
| Gross Margin | 17.65% |
| Operating Margin | -1.29% |
| Profit Margin | -21.10% |
Ownership
| Insider Ownership | 10.32% |
| Institutional Ownership | 84.33% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -18.65 |
| PEG | 1.89 |
| P/S | 1.41 |
| P/B | 1.32 |
Analyst Data
| Recommendation | buy |
| Target Price | $9.88 |
Technical Indicators
| SMA20 | $8.67 |
| SMA50 | $8.16 |
| SMA200 | $6.02 |
| RSI | 61.34 |
| ATR | 0.3836 |
| Shares Float | 186.83M |
| Short Float | 3.96% |
| Short Ratio | 5.00 |
| Volatility | 2.29 |
| Rel Volume | 1.65 |
Performance History
| Week | +0.68% |
| Month | +3.26% |
| Quarter | +24.08% |
| 6 Months | +84.39% |
| YTD | +78.47% |
| Year | +147.48% |
| 3 Years | +197.63% |
| 5 Years | +139.80% |
| 10 Years | -33.51% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $8.86 | 3,369,000 |
| 2026-06-17 | $8.59 | 1,671,700 |
| 2026-06-16 | $8.79 | 1,760,200 |
| 2026-06-15 | $8.83 | 1,870,400 |
| 2026-06-12 | $9.03 | 1,443,700 |
| 2026-06-11 | $8.80 | 1,639,200 |
| 2026-06-10 | $8.87 | 1,758,000 |
| 2026-06-09 | $8.79 | 4,042,400 |
| 2026-06-08 | $8.30 | 2,609,900 |
| 2026-06-05 | $8.53 | 1,901,600 |
| 2026-06-04 | $8.60 | 1,864,300 |
| 2026-06-03 | $8.54 | 1,706,400 |
| 2026-06-02 | $8.50 | 2,651,200 |
| 2026-06-01 | $8.21 | 1,596,800 |
| 2026-05-29 | $8.32 | 3,760,300 |
| 2026-05-28 | $8.61 | 1,148,600 |
| 2026-05-27 | $8.82 | 2,210,200 |
| 2026-05-26 | $8.82 | 1,666,800 |
| 2026-05-22 | $8.75 | 1,007,600 |
| 2026-05-21 | $8.90 | 1,070,200 |
| 2026-05-20 | $9.13 | 2,805,800 |
| 2026-05-19 | $8.58 | 1,476,100 |
About Diversified Healthcare Trust
Diversified Healthcare Trust is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of March 31, 2026, DHC's approximately 6.2 billion dollars portfolio included 285 properties in 33 states and Washington, D.C., with 23,901 senior living units, approximately 5.6 million square feet of medical office and life science properties and occupied by approximately 250 tenants. DHC is managed by The RMR Group, a leading U.S. alternative asset management company with over 37 billion dollars in assets under management as of March 31, 2026 and 40 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquarters in Newton, MA. Diversified Healthcare Trust was incorporated in 1998 in Maryland.
đ° Latest News
Diversified Healthcare (DHC) Upgraded to Buy: What Does It Mean for the Stock?
Zacks âĸ 2026-06-18T16:00:06ZDiversified Healthcare (DHC) is a Great Momentum Stock: Should You Buy?
Zacks âĸ 2026-06-15T16:00:03ZDiversified Healthcare (DHC) Surges 5.9%: Is This an Indication of Further Gains?
Zacks âĸ 2026-06-10T11:49:00ZIs It Too Late To Consider Diversified Healthcare Trust (DHC) After Its Recent 176% Surge?
Simply Wall St. âĸ 2026-05-12T22:17:14ZThe RMR Group Q2 Earnings Call Highlights
MarketBeat âĸ 2026-05-09T00:07:42ZDiversified Healthcare Trust Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-05T15:47:02ZDiversified Healthcare Trust Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-05T12:30:00ZDiversified Healthcare (DHC) Tops Q1 FFO Estimates
Zacks âĸ 2026-05-04T23:30:03ZIs Diversified Healthcare Trust (DHC) A Good Stock To Buy Now?
Insider Monkey âĸ 2026-05-03T19:47:21ZDid Narrowing Losses And NOI Focus Just Shift Diversified Healthcare Trust's (DHC) Investment Narrative?
Simply Wall St. âĸ 2026-03-09T07:13:49ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,259,227,000 | $1,236,436,000 | $1,174,393,000 | $1,108,825,000 |
| Cost Of Revenue | $1,259,340,000 | $1,236,542,000 | $1,174,151,000 | $1,109,070,000 |
| Total Revenue | $1,537,853,000 | $1,495,427,000 | $1,410,308,000 | $1,283,566,000 |
| Operating Revenue | $1,537,853,000 | $1,495,427,000 | $1,410,308,000 | $1,283,566,000 |
| Expenses | ||||
| Interest Expense | $204,498,000 | $235,239,000 | $191,775,000 | $209,383,000 |
| Total Expenses | $1,566,765,000 | $1,548,017,000 | $1,484,365,000 | $1,374,785,000 |
| Other Income Expense | $-93,332,000 | $-92,506,000 | $-22,370,000 | $263,554,000 |
| Net Non Operating Interest Income Expense | $-198,659,000 | $-226,289,000 | $-176,239,000 | $-193,454,000 |
| Interest Expense Non Operating | $204,498,000 | $235,239,000 | $191,775,000 | $209,383,000 |
| Operating Expense | $307,425,000 | $311,475,000 | $310,214,000 | $265,715,000 |
| General And Administrative Expense | $45,502,000 | $26,518,000 | $26,131,000 | $26,435,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-285,886,000 | $-370,255,000 | $-293,572,000 | $-15,774,000 |
| Net Interest Income | $-198,659,000 | $-226,289,000 | $-176,239,000 | $-193,454,000 |
| Interest Income | $5,839,000 | $8,950,000 | $15,536,000 | $15,929,000 |
| Normalized Income | $-212,153,720 | $-297,175,260 | $-275,899,700 | $-223,981,660 |
| Net Income From Continuing And Discontinued Operation | $-285,886,000 | $-370,255,000 | $-293,572,000 | $-15,774,000 |
| Net Income Common Stockholders | $-285,886,000 | $-370,255,000 | $-293,572,000 | $-15,774,000 |
| Net Income | $-285,886,000 | $-370,255,000 | $-293,572,000 | $-15,774,000 |
| Net Income Including Noncontrolling Interests | $-285,886,000 | $-370,255,000 | $-293,572,000 | $-15,774,000 |
| Net Income Continuous Operations | $-285,886,000 | $-370,255,000 | $-293,572,000 | $-15,774,000 |
| Earnings From Equity Interest Net Of Tax | $36,760,000 | $1,597,000 | $-20,461,000 | $6,055,000 |
| Pretax Income | $-320,903,000 | $-371,385,000 | $-272,666,000 | $-21,119,000 |
| Special Income Charges | $-211,062,000 | $-73,568,000 | $-31,701,000 | $-32,648,000 |
| Interest Income Non Operating | $5,839,000 | $8,950,000 | $15,536,000 | $15,929,000 |
| Operating Income | $-28,912,000 | $-52,590,000 | $-74,057,000 | $-91,219,000 |
| Depreciation Amortization Depletion Income Statement | $261,923,000 | $284,957,000 | $284,083,000 | $239,280,000 |
| Depreciation And Amortization In Income Statement | $261,923,000 | $284,957,000 | $284,083,000 | $239,280,000 |
| Gross Profit | $278,513,000 | $258,885,000 | $236,157,000 | $174,496,000 |
| Per Share | ||||
| Diluted EPS | $-1.19 | $-1.55 | $-1.23 | $-0.07 |
| Basic EPS | $-1.19 | $-1.55 | $-1.23 | $-0.07 |
| Other | ||||
| Tax Effect Of Unusual Items | $-19,599,720 | $-19,426,260 | $-4,697,700 | $55,346,340 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $238,963,000 | $241,423,000 | $225,562,000 | $164,235,000 |
| Total Unusual Items | $-93,332,000 | $-92,506,000 | $-22,370,000 | $263,554,000 |
| Total Unusual Items Excluding Goodwill | $-93,332,000 | $-92,506,000 | $-22,370,000 | $263,554,000 |
| Reconciled Depreciation | $262,036,000 | $285,063,000 | $283,841,000 | $239,525,000 |
| EBITDA (Bullshit earnings) | $145,631,000 | $148,917,000 | $203,192,000 | $427,789,000 |
| EBIT | $-116,405,000 | $-136,146,000 | $-80,891,000 | $188,264,000 |
| Diluted Average Shares | $240,286,000 | $239,535,000 | $238,836,000 | $238,314,000 |
| Basic Average Shares | $240,286,000 | $239,535,000 | $238,836,000 | $238,314,000 |
| Diluted NI Availto Com Stockholders | $-285,886,000 | $-370,255,000 | $-293,572,000 | $-15,774,000 |
| Tax Provision | $1,743,000 | $467,000 | $445,000 | $710,000 |
| Other Special Charges | $35,004,000 | $324,000 | $2,468,000 | $30,043,000 |
| Impairment Of Capital Assets | $165,702,000 | $70,734,000 | $18,380,000 | $0 |
| Restructuring And Mergern Acquisition | $10,356,000 | $2,510,000 | $10,853,000 | $2,605,000 |
| Gain On Sale Of Security | $117,730,000 | $-18,938,000 | $9,331,000 | $296,202,000 |
| Selling General And Administration | $45,502,000 | $26,518,000 | $26,131,000 | $26,435,000 |
| Other Gand A | $45,502,000 | $26,518,000 | $26,131,000 | $26,435,000 |
| Minority Interests | - | - | $0 | $0 |
| Write Off | - | - | - | $0 |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $1,644,905,000 | $1,932,543,000 | $2,302,943,000 | $2,593,260,000 |
| Total Assets | $4,361,250,000 | $5,137,005,000 | $5,446,136,000 | $6,002,093,000 |
| Total Non Current Assets | $4,212,393,000 | $4,706,824,000 | $5,183,647,000 | $5,304,690,000 |
| Other Non Current Assets | $185,504,000 | $188,600,000 | $222,159,000 | $233,791,000 |
| Goodwill And Other Intangible Assets | $20,663,000 | $26,300,000 | $33,948,000 | $45,351,000 |
| Current Assets | $148,857,000 | $430,181,000 | $262,489,000 | $697,403,000 |
| Assets Held For Sale Current | $23,085,000 | $276,270,000 | $9,447,000 | $385,000 |
| Restricted Cash | $16,392,000 | $5,270,000 | $1,022,000 | $30,237,000 |
| Receivables | $3,973,000 | $4,057,000 | $6,081,000 | $8,716,000 |
| Cash Cash Equivalents And Short Term Investments | $105,407,000 | $144,584,000 | $245,939,000 | $658,065,000 |
| Cash And Cash Equivalents | $105,407,000 | $144,584,000 | $245,939,000 | $658,065,000 |
| Investmentin Financial Assets | - | - | $0 | $5,880,000 |
| Debt | ||||
| Net Debt | $2,295,417,000 | $2,766,320,000 | $2,570,910,000 | $2,389,812,000 |
| Total Debt | $2,400,824,000 | $2,910,904,000 | $2,816,849,000 | $3,047,877,000 |
| Long Term Debt And Capital Lease Obligation | $2,400,824,000 | $2,910,904,000 | $2,816,849,000 | $2,347,877,000 |
| Long Term Debt | $2,400,824,000 | $2,910,904,000 | $2,816,849,000 | $2,347,877,000 |
| Current Debt And Capital Lease Obligation | - | - | - | $700,000,000 |
| Current Debt | - | - | - | $700,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,695,682,000 | $3,178,162,000 | $3,109,245,000 | $3,363,482,000 |
| Total Non Current Liabilities Net Minority Interest | $2,638,874,000 | $3,140,057,000 | $3,079,305,000 | $2,628,863,000 |
| Other Non Current Liabilities | $238,050,000 | $229,153,000 | $262,456,000 | $280,986,000 |
| Current Liabilities | $56,808,000 | $38,105,000 | $29,940,000 | $734,619,000 |
| Other Current Liabilities | $3,426,000 | $6,024,000 | $32,000 | - |
| Payables And Accrued Expenses | $53,382,000 | $32,081,000 | $29,908,000 | $34,619,000 |
| Interest Payable | $30,683,000 | $23,092,000 | $22,847,000 | $29,417,000 |
| Payables | $22,699,000 | $8,989,000 | $7,061,000 | $5,202,000 |
| Equity | ||||
| Common Stock Equity | $1,665,568,000 | $1,958,843,000 | $2,336,891,000 | $2,638,611,000 |
| Total Equity Gross Minority Interest | $1,665,568,000 | $1,958,843,000 | $2,336,891,000 | $2,638,611,000 |
| Stockholders Equity | $1,665,568,000 | $1,958,843,000 | $2,336,891,000 | $2,638,611,000 |
| Gains Losses Not Affecting Retained Earnings | $-12,000 | $-17,000 | $0 | - |
| Other Equity Adjustments | $-12,000 | $-17,000 | - | - |
| Retained Earnings | $-2,959,413,000 | $-2,663,866,000 | $-2,283,984,000 | $-1,980,817,000 |
| Long Term Equity Investment | $147,326,000 | $151,449,000 | $129,916,000 | $155,477,000 |
| Investments In Other Ventures Under Equity Method | - | $24,590,000 | $0 | - |
| Other | ||||
| Ordinary Shares Number | $242,121,025 | $241,271,703 | $240,423,898 | $239,694,842 |
| Share Issued | $242,121,025 | $241,271,703 | $240,423,898 | $239,694,842 |
| Tangible Book Value | $1,644,905,000 | $1,932,543,000 | $2,302,943,000 | $2,593,260,000 |
| Invested Capital | $4,066,392,000 | $4,869,747,000 | $5,153,740,000 | $5,686,488,000 |
| Working Capital | $92,049,000 | $392,076,000 | $232,549,000 | $-37,216,000 |
| Total Capitalization | $4,066,392,000 | $4,869,747,000 | $5,153,740,000 | $4,986,488,000 |
| Additional Paid In Capital | $4,622,572,000 | $4,620,313,000 | $4,618,470,000 | $4,617,031,000 |
| Capital Stock | $2,421,000 | $2,413,000 | $2,405,000 | $2,397,000 |
| Common Stock | $2,421,000 | $2,413,000 | $2,405,000 | $2,397,000 |
| Line Of Credit | $0 | $0 | $0 | $700,000,000 |
| Current Accrued Expenses | $30,683,000 | $23,092,000 | $22,847,000 | $29,417,000 |
| Dueto Related Parties Current | $22,699,000 | $8,989,000 | $7,061,000 | $5,202,000 |
| Investments And Advances | $147,326,000 | $151,449,000 | $129,916,000 | $161,357,000 |
| Investmentsin Joint Venturesat Cost | $120,126,000 | $126,859,000 | $129,916,000 | $155,477,000 |
| Investmentsin Associatesat Cost | $27,200,000 | $24,590,000 | $0 | - |
| Investment Properties | $3,858,900,000 | $4,340,475,000 | $4,797,624,000 | $4,864,191,000 |
| Duefrom Related Parties Current | $3,973,000 | $4,057,000 | $6,081,000 | $8,716,000 |
| Minority Interest | - | - | $0 | $0 |
| Capital Lease Obligations | - | - | - | $30,177,000 |
| Long Term Capital Lease Obligation | - | - | - | $30,177,000 |
| Available For Sale Securities | - | - | - | $5,880,000 |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-19,618,000 | $112,223,000 | $10,483,000 | $-40,353,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-19,618,000 | $112,223,000 | $10,483,000 | $-40,353,000 |
| Cash Flow From Continuing Operating Activities | $-19,618,000 | $112,223,000 | $10,483,000 | $-40,353,000 |
| Operating Gains Losses | $-111,964,000 | $17,665,000 | $13,598,000 | $-272,214,000 |
| Investing Activities | ||||
| Investing Cash Flow | $483,572,000 | $-187,019,000 | $-202,111,000 | $387,708,000 |
| Cash Flow From Continuing Investing Activities | $483,572,000 | $-187,019,000 | $-202,111,000 | $387,708,000 |
| Net Other Investing Changes | $1,308,000 | $1,698,000 | $14,540,000 | $14,466,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-1,145,000 | $-904,000 | $-393,000 | $-171,000 |
| Financing Cash Flow | $-492,009,000 | $-22,311,000 | $-249,713,000 | $-675,998,000 |
| Cash Flow From Continuing Financing Activities | $-492,009,000 | $-22,311,000 | $-249,713,000 | $-675,998,000 |
| Net Other Financing Charges | $-59,891,000 | $-8,562,000 | $-22,677,000 | $-27,192,000 |
| Cash Dividends Paid | $-9,661,000 | $-9,627,000 | $-9,595,000 | $-9,568,000 |
| Common Stock Dividend Paid | $-9,661,000 | $-9,627,000 | $-9,595,000 | $-9,568,000 |
| Net Common Stock Issuance | $-1,145,000 | $-904,000 | $-393,000 | $-171,000 |
| Dividends Received Cfi | $48,400,000 | $0 | $0 | $0 |
| Dividend Received Cfo | $1,000,000 | $1,231,000 | $5,100,000 | $8,769,000 |
| Other | ||||
| Repayment Of Debt | $-1,133,844,000 | $-123,218,000 | $-967,049,000 | $-639,067,000 |
| Issuance Of Debt | $712,532,000 | $120,000,000 | $750,001,000 | $0 |
| Interest Paid Supplemental Data | $271,834,000 | $131,557,000 | $186,534,000 | $201,153,000 |
| Income Tax Paid Supplemental Data | $1,776,000 | $484,000 | $677,000 | $935,000 |
| End Cash Position | $121,799,000 | $149,854,000 | $246,961,000 | $688,302,000 |
| Beginning Cash Position | $149,854,000 | $246,961,000 | $688,302,000 | $1,016,945,000 |
| Changes In Cash | $-28,055,000 | $-97,107,000 | $-441,341,000 | $-328,643,000 |
| Common Stock Payments | $-1,145,000 | $-904,000 | $-393,000 | $-171,000 |
| Net Issuance Payments Of Debt | $-421,312,000 | $-3,218,000 | $-217,048,000 | $-639,067,000 |
| Net Long Term Debt Issuance | $-421,312,000 | $-3,218,000 | $-217,048,000 | $-639,067,000 |
| Long Term Debt Payments | $-1,133,844,000 | $-123,218,000 | $-967,049,000 | $-639,067,000 |
| Long Term Debt Issuance | $712,532,000 | $120,000,000 | $750,001,000 | $0 |
| Interest Received Cfi | $-47,000 | $0 | $0 | - |
| Net Investment Properties Purchase And Sale | $442,411,000 | $-167,535,000 | $-216,651,000 | $264,818,000 |
| Sale Of Investment Properties | $589,234,000 | $34,167,000 | $18,356,000 | $639,310,000 |
| Purchase Of Investment Properties | $-146,823,000 | $-201,702,000 | $-235,007,000 | $-374,492,000 |
| Net Business Purchase And Sale | $-8,500,000 | $-21,182,000 | $0 | $108,424,000 |
| Purchase Of Business | $-8,500,000 | $-21,182,000 | $0 | $0 |
| Interest Paid Cfo | $-152,869,000 | $0 | $0 | - |
| Change In Working Capital | $33,264,000 | $6,818,000 | $-27,838,000 | $1,637,000 |
| Change In Other Working Capital | $-4,313,000 | $-3,578,000 | $-9,834,000 | $-7,874,000 |
| Change In Other Current Liabilities | $32,639,000 | $-6,521,000 | $-22,106,000 | $-1,007,000 |
| Change In Other Current Assets | $-2,653,000 | $16,672,000 | $10,672,000 | $10,946,000 |
| Change In Payables And Accrued Expense | $7,591,000 | $245,000 | $-6,570,000 | $-428,000 |
| Change In Accrued Expense | $7,591,000 | $245,000 | $-6,570,000 | $-428,000 |
| Change In Interest Payable | $7,591,000 | $245,000 | $-6,570,000 | $-428,000 |
| Other Non Cash Items | $69,099,000 | $100,967,000 | $10,974,000 | $-2,296,000 |
| Asset Impairment Charge | $165,702,000 | $70,734,000 | $18,380,000 | $0 |
| Depreciation Amortization Depletion | $262,036,000 | $285,063,000 | $283,841,000 | $239,525,000 |
| Depreciation And Amortization | $262,036,000 | $285,063,000 | $283,841,000 | $239,525,000 |
| Amortization Cash Flow | $113,000 | $106,000 | $-242,000 | $245,000 |
| Amortization Of Intangibles | $113,000 | $106,000 | $-242,000 | $245,000 |
| Depreciation | $261,923,000 | $284,957,000 | $284,083,000 | $239,280,000 |
| Earnings Losses From Equity Investments | $-36,760,000 | $-1,597,000 | $20,461,000 | $-6,055,000 |
| Gain Loss On Investment Securities | $-117,730,000 | $18,938,000 | $-9,331,000 | $-296,202,000 |
| Net Income From Continuing Operations | $-285,886,000 | $-370,255,000 | $-293,572,000 | $-15,774,000 |
| Sale Of Business | - | $0 | $0 | $108,424,000 |
| Net Short Term Debt Issuance | - | - | $-700,000,000 | $-100,000,000 |
| Short Term Debt Payments | - | - | $-700,000,000 | $-100,000,000 |
| Short Term Debt Issuance | - | - | $0 | $0 |
| Net Investment Purchase And Sale | - | - | - | - |
| Sale Of Investment | - | - | - | - |